Marina Closes Financing with Potential Value of $8.7M
November 11, 2010
Marina Closes Financing with Potential Value of $8.7M
The company said it sold approximately 1.8 million shares of its common stock at $1.84 per share in an initial financing with gross proceeds of $3.3 million.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Marina, on Track with FAP Drug, Starts Looking to Raise Needed Cash
May 19, 2011 / Gene Silencing News - Silence Plans $28.6M Stock Sale to Fund Expansion of Staff, Pipeline
April 11, 2013 / Gene Silencing News - Marina Defaults on Loan as Bankruptcy Looms
January 31, 2013 / Gene Silencing News - Gradalis Raises $24M in Series B
January 3, 2013 / Gene Silencing News - Marina Extends Cash Runway to Year End, Sells Off Equipment
December 13, 2012 / Gene Silencing News